e-learning
resources
Virtual 2021
06.09.2021
Highlights in COVID-19 diagnosis and treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Do hospitalized COVID-19 patients have endothelial vascular dysfunction? A cohort study
M. OLIVEIRA (São Carlos, Brazil), G. Back (São Carlos, Brazil), C. Goulart (São Carlos, Brazil), B. Domingos (São Carlos, Brazil), R. Arena (Chicago, United States of America), A. Borghi-Silva (São Carlos, Brazil)
Source:
Virtual Congress 2021 – Highlights in COVID-19 diagnosis and treatment
Session:
Highlights in COVID-19 diagnosis and treatment
Session type:
Oral Presentation
Number:
2659
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. OLIVEIRA (São Carlos, Brazil), G. Back (São Carlos, Brazil), C. Goulart (São Carlos, Brazil), B. Domingos (São Carlos, Brazil), R. Arena (Chicago, United States of America), A. Borghi-Silva (São Carlos, Brazil). Do hospitalized COVID-19 patients have endothelial vascular dysfunction? A cohort study. 2659
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Systemic endothelial dysfunction in COPD patients – study on 60 cases
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004
Evaluation of endothelial dysfunction at the patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 316s
Year: 2004
1 year evolution of COPD patients systemic endothelial dysfunction
Source: Eur Respir J 2005; 26: Suppl. 49, 718s
Year: 2005
Pulmonary vascular disease (PVD) in patients with Sjögren syndrome - a prospective cross-sectional study
Source: International Congress 2019 – Pulmonary arterial hypertension: recent advances from the bedside
Year: 2019
Determinants of endothelial function in patients with COPD
Source: Eur Respir J 2013; 42: 1194-1204
Year: 2013
Endothelial dysfunction and increased platelet reactivity in patients with acute coronary syndrome and undiagnosed COPD: insights into the SCAP trial
Source: Eur Respir J, 50 (4) 1701183; 10.1183/13993003.01183-2017
Year: 2017
Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension
Source: Eur Respir J 2007; 30: Suppl. 51, 768s
Year: 2007
Hypoxaemia and endothelial dysfunctional in patients with COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009
New markers of endothelial dysfunction in patients with COPD
Source: Annual Congress 2009 - Pulmonary hypertension
Year: 2009
Correction of endothelial dysfunction in patients with COPD, IPF
Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease
Year: 2010
New markers of endothelial dysfunction in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 143s
Year: 2007
Pulmonary hypertension and endothelial dysfunction in patients with COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 605s
Year: 2007
Multi-institutional prospective cohort study of prognostic factors in patients with idiopathic pulmonary fibrosis receiving long-term oxygen therapy.
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019
Correction of endothelial dysfunction in patients with pulmonary diseases
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
How do patients with vascular rings/slings die?
Source: Annual Congress 2008 - The use of fibreoptic bronchoscopy in children with diffuse or localised lung disease
Year: 2008
The role of smoking in development of endothelial dysfunction in patients with COPD in combination with AH
Source: Annual Congress 2011 - Anti-smoking interventions: prevention and treatment
Year: 2011
Do COPD patients have a pulmonary vascular phenotype?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
Vascular dysfunction and systemic inflammation in patients with COPD
Source: Annual Congress 2011 - COPD: human studies
Year: 2011
Respiratory function in chronic stroke patients: an observational study.
Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions
Year: 2021
Prevalence of pulmonary embolism in patients with isolated syncope in the emergency department: the PEEPS multicenter prospective cohort study.
Source: International Congress 2019 – Pulmonary embolism: from diagnosis to prognosis and treatment
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept